The aim of this study to evaluate clinical and management of penile cancer patients at Sardjito Hospital. Data were collected from medical record of Sardjito Hospital from 2006 - 2013. The clinical factors and therapy were studied from each patient. Correlation between age and stadium of disease were analyzed using Chi-Square Test while the correlation among pathological grade and T, N and M stage were analyzed by using Fisher Test. There are 35 cases of penile cancer with mostly of 40-60 years old man (45.7%) , circumcised (42.9%), squamos cell type (91.4%) and perform partial penectomy (45.7%) followed by chemotherapy (6 patients) and radiotherapy (4patients). There are no correlation between age and stadium of cancer (P>0.05), also among pathological grade with T, N and M Stage (P>0.05). Penile cancers at Sardjito Hospital mostly found on 40-60 years old, and already developed into advanced disease. Thetherapy is consist of partial penectomy followed by chemo- radiotherapy.ABSTRAKPenelitian ini bertujuan untuk mengevaluasi klinis dan manajemen kanker penis di Rumah Sakit Sardjito. Data dikumpulkan dari rekam medis RS Sardjito tahun 2006-2013. Faktor klinis dan terapi dipelajari dari tiap pasien. Hubungan antara usia dan stadium penyakit dianalisis menggunakan tes Chi-Square, sedangkan hubungan antara tingkatan histopatologi dengan stadium T, N, M dianalisis dengan tes Fisher. Ada 35 kasus kanker penis dengandominan pada usia 40-60 tahun (45,7%); telah disunat (42,9%); tipe karsinoma sel skuamosa (91,4%); dan dilakukan penektomi parsial (45,7%) diikuti dengan kemoterapi (6 pasien) serta radioterapi (4 pasien). Tidak ada hubungan antara usia dengan stadium penyakit (>0,05) dan juga antara tingkatan histopatologi dengan stadium T, N, M (p>0,05). Kanker penis di RS Sardjito kebanyakan ditemukan pada usia 40-60 tahun dan telah berkembang menjadi tingkat lanjut. Terapi terdiri dari penektomi parsial diikuti kemo-radioterapi.

Objective: To know survival of germ cell testicle tumor at Sardjito hospital who had chemotherapy or radiotherapy and its factor which influenced their survivalMethod: From year 2007 until 2013, we collected patients with germ cell testicle tumor at Sardjito hospital who had chemotherapy or radiotherapy. The clinical factor that studied were age, histopathology findings, the TNMS staging, clinical staging, therapy and survival status. We evaluate their survival up to five years after therapy. Correlation between survival status with age, histopathology findings, the TNMS staging, clinical staging,therapy and prognosis were analyzed using Fisher Exact Test. The Kaplan Meier survival analysis was used to calculate survival of germ cell testicle tumor. Result: There are 23 patient of germ cell testicle tumor whom 21 patients had chemotherapy and 2 patients had radiotherapy. There are no correlation between survival status with age, histopathology findings, the TNMS staging, clinical staging, therapy and prognosis (p>0.05). Based on Kaplan Meier survival analysis, their survival were better on age < 30 years old (p=0.534), seminoma type (p=0.860), had chemotherapy (p=0.599), T3 (p=0.031), Nx (p=0.394), Mx (p=0.781), 51 staging (p=0.623) dan 3rdstadium (p=0.732). Based on risk classification, survival of seminoma with intermediate prognosis were better than seminoma with good prognosis (p=0.631) whereas survival of non seminoma with good prognosis were higher than non seminoma with intermediate or poor prognosis (p=0.014). Conclusion: Germ cell testicle tumor at Sardjito hospital had dominant of seminoma type and had already developed into advanced staged with chemoterapy as therapy. Survival of germ cell testicle tumor were lower than other country. T3 staging and non seminoma with good prognosis could be prognostic factor of germ cell testicle tumor at Sardjito hospital.ABSTRAKObjektif: Untuk mengetahui gambaran ketahanan hidup pasien tumor testis jenis sel germinal di RS Sardjito yang dilakukan kemoterapi maupun radioterapi serta faktor-faktor yang mempengaruhi ketahanan hidup tumor testis jenis sel germinal Bahan dan cara: Dari tahun 2007-2013, dilakukan pendataan pasien dengan tumor testis jenis sel germinal di RS Sardjito baik yang dilakukan kemoterapi maupun radioterapi. Data yang dipelajari adalah usia, jenis histopatologi, stadium T, N, M, S, stadium klinis dan status ketahanan hidup. Dilakukan evaluasi ketahanan hidup hingga 5 tahun post terapi. Dilakukan analisa bivariat menggunakan tes Fisher untuk menilai hubungan antara ketahanan hidup dengan faktor-faktor seperti usia, jenis histopatologi, stadium T, N, M, S, stadium klinis, jenis terapi dan prognosis. Digunakan kurva Kaplan Meier untuk menilai gambaran ketahanan hidup pasien tumor testis sel germinal. Hasil: Ada 23 pasien tumor testis jenis sel germinal di RS Sardjito periode 2007-2013 dimana 21 pasien mendapatkan kemoterapi dan 2 pasien mendapatkan radioterapi. Tidak dijumpai hubungan bermakna antara ketahanan hidup pasien tumor buli jenis sel germinal dengan usia, jenis histopatologi, stadium T, N, M, S, stadium klinis dan prognosis(p>0.05). Berdasarkan kurva Kaplan Meier diketahui ketahanan hidup tumor testis sel germinal lebih baik pada usia < 30 tahun (p=0.534), jenis non seminoma (p=0.860), stadium T3 (p=0.031), Nx (p=0.394), Mx (p=0.781), S1 (p=0.623) dan stadium 3 (p=0.732). Berdasarkan klasifikasi resiko, ketahanan hidup tumor testis jenis seminoma dengan prognosis sedang lebih baik dibandingkan tumor testis jenis seminoma dengan prognosis baik (p=0.631) sedangkan ketahanan hidup jenis non seminoma dengan prognosis baik lebih tinggi dibandingkan tumor testis jenis non seminoma dengan prognosis sedang dan buruk (p=0.014). Kesimpulan: Tumor testis sel germinal di RS Sardjito mayoritas jenis seminoma dan sudah dalam stadium lanjut dengan kemoterapi sebagai sarana terapi. Angka ketahanan hidup tumor testis jenis sel germinallebih rendah dibandingkan negara lain. Stadium T3 dan grup non seminoma prognosis baik dapat dijadikan faktor prognostik ketahanan hidup tumor testis sel germinal di RS Sardjito.

Objective: To evaluate the survival on patient who had muscle invasive bladder cancer that had been operated or radiotherapy at Sardjito Hospital Yogyakarta. Material & method: From the year 2004-2010, we were data the patients with muscle invasive bladder cancer that had been operated or radiotherapy at Sardjito Hospital. We studied the age when diagnosed, gender, TNM status, histophatologic finding, histophatologic grade, kinds of surgery and status when follow-up. We evaluated the survival of each patient until 5-years post-surgery. We did bivariate analyze to assess the correlation of patient survival and TNM status, histophatologic grade, clinical stadium and kinds of management. We use Kaplan Meier curve to assess the the survival of patient who had muscle invasive bladder cancer. Results: There were 37 patients with bladder cancer, 3 female patients (8.1%) and 34 male patients (91.9%). Five patients were performed radical cystectomy, 4 patients performed partial cystectomy and 28 patients performed TUR-BT and radiotherapy. There were no significant correlation on the patient survival who had muscle invasive bladder cancer with gender, age, stadium, TNM staging, histopathologic grade and kinds of management (p>0.05). From Kaplan Meier curve, we found that the patients survival was better on stadium I, staging T1, N0, M0 and histopathologic G1 grade. While based on kinds of management, patients were performed partial cystectomy had the survival rate better than the one who only performed TUR-BT and radiotherapy. Conclusion: The surgery of partial cystectomy had a better survival rate than TUR-BT and radiotherapy..